Verseon Competitors and Similar CompaniesClear all
Verseon's competitors and similar companies include Curi Bio, Walvax Biotechnology, SIGA Technologies and Biora Therapeutics.
 Curi Bio Curi Bio is a biotechnology company developing human-relevant platforms and advanced tissue models for drug discovery and development. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. |  SIGA Technologies SIGA Technologies is a biopharmaceutical company that develops treatments for infectious diseases. |  Biora Therapeutics Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services. | ||
Founding Date | Founding Date 2002 | Founding Date 2015 | Founding Date 2001 | Founding Date 1995 | Founding Date 2010 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | Tags Healthcare | ||||
Locations | Locations Fremont, US HQ | Locations Seattle, US HQ | Locations Kunming, CN HQ | Locations New York, US HQ Corvallis, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 244% decrease | Employees 44 | Employees 2,388 | Employees 4515% increase | Employees 5456% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.3 b | Valuation ($) 507.4 m | Valuation ($) 16.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) $94.6m (FY, 2025) | Revenue (est.) $4k (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods $29.7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit $64.9m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ¥125.2m (FY, 2025) | Net income $23.3m (FY, 2025) | Net income ($124.1m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 6m | Total funding raised $ 72.8m | Total funding raised N/A | Total funding raised $ 138.5m |
For sources of this data, please see the company profile
View Company Profiles
Curi Bio
HQ
Seattle, US
Employees
44
Curi Bio is a biotechnology company developing human-relevant platforms and advanced tissue models for drug discovery and development.
View companyWalvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View companySIGA Technologies
HQ
New York, US
Employees
45↑ 15% increase
SIGA Technologies is a biopharmaceutical company that develops treatments for infectious diseases.
View companyBiora Therapeutics
HQ
San Diego, US
Employees
54
Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services.
View company